Trouble Spots in Online Direct-To-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters

International Journal of Health Policy and Management - Iran
doi 10.15171/ijhpm.2015.157
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Maad Rayan Publishing Company

Related search

Trouble Spots in Online Direct-To-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-To-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"

International Journal of Health Policy and Management
Health Information ManagementManagementMonitoringHealth PolicyLeadershipHealthPolicyLaw
2016English

The Educational Potential of Direct-To-Consumer Prescription Drug Advertising

Health Affairs
MedicineHealth Policy
2004English

279 Content Analysis of Psoriasis and Eczema Direct to Consumer Advertisements

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Direct-To-Consumer Advertising and Online Search

SSRN Electronic Journal
2016English

Direct-To-Consumer Advertising and Online Search

2016English

Demand Effects of Recent Changes in Prescription Drug Promotion

2003English

FDA Warning to Manufacturers of AIDS Drugs

Western Journal of Medicine
2001English

How Direct-To-Consumer Advertising for Prescription Drugs Affects Consumers' Welfare

Journal of Advertising Research
CommunicationMarketing
2016English

Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales

Journal of Law and Economics
LawEconomicsEconometrics
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy